Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00733590 · ClinicalTrials.gov registry record

Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention

A clinical trial of Heart Failure, Congestive and Cardiomyopathies, sponsored by Johns Hopkins University.

Recruiting
Registry status
1,500
Enrollment target
4
Study locations

NCT00733590: Recruiting study of Heart Failure, Congestive and Cardiomyopathies, sponsored by Johns Hopkins University.

NCT00733590 is a study of Heart Failure, Congestive and Cardiomyopathies that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 1,500 participants, above the 636-participant average among 39 other Heart Failure, Congestive trials with a reported enrollment target (136% higher). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00733590, a study of Heart Failure, Congestive and Cardiomyopathies, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
1,500 participants
Enrollment target
4
Study locations

Study Summary

The overall hypothesis of this study is that subtle interactions between structural (substrate) and functional (trigger) abnormalities of the heart, some of which are genetically-determined, can be used to identify patients at high risk of sudden cardiac death (SCD). Such information may be used to better define patients most likely to benefit from replacement of an internal defibrillator (ICD). The prospective, observational study to enroll, categorize and follow patients who receive an ICD pulse generator replacement for primary prevention of SCD (PROSe-ICD) was established to : 1. to gain a better understanding of the biological mechanisms that predispose to SCD 2. to develop readily determined clinical, electrocardiographic, genetic and blood protein markers identify patients with an increased risk of dying suddenly

Study Locations (4)

Maryland

  • University of Maryland Medical Center - Baltimore
  • Johns Hopkins University School of Medicine - Baltimore

District of Columbia

  • Washington Hospital Center - Washington D.C.

Virginia

  • Virginia Commonwealth University School of Medicine - Richmond

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2003-06
Est. Completion 2029-03
Johns Hopkins University

1,448 total trials

What NCT00733590 shows while recruiting

NCT00733590 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 636-participant average among 39 other Heart Failure, Congestive trials with a reported enrollment target (136% higher).

The record links to 4 conditions, with Heart Failure, Congestive appearing as the primary indexed condition, and to 0 interventions.

NCT00733590 reports a single indexed study location in Maryland, District of Columbia, Virginia.

Frequently Asked Questions

What is clinical trial NCT00733590 about?

NCT00733590 is a clinical study titled "Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention". The overall hypothesis of this study is that subtle interactions between structural (substrate) and functional (trigger) abnormalities of the heart, some of which are genetically-determined, can be used to identify patients at high risk of sudden cardiac death (SCD). Such information may be used to ...

What is the current status of trial NCT00733590?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2003-06. Estimated completion is 2029-03.

What conditions does trial NCT00733590 study?

This clinical trial studies the following conditions: Heart Failure, Congestive, Cardiomyopathies, Arrhythmia, Death, Sudden, Cardiac.

Who is sponsoring clinical trial NCT00733590?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00733590 being conducted?

This trial has 4 study locations across District of Columbia, Maryland, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure, Congestive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00733590's enrollment target sits among peer trials

1,500 7th of 39 higher than 33 of 39 other Heart Failure, Congestive trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure, Congestive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00733590, the US trial registry maintained by the National Library of Medicine. NCT00733590 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.